Article Text

Download PDFPDF
Meta-analysis of α synuclein/ NACP polymorphism in Parkinson's disease in Japan
  1. I Mizuta,
  2. M Nishimura*,
  3. E Mizuta,
  4. S Yamasaki,
  5. M Ohta**,
  6. S Kuno
  1. Clinical Research Centre, Utano National Hospital, Kyoto 616-8255, Japan
  1. Correspondence to:
 Dr S Kuno, Clinical Research Centre, Utano National Hospital, Kyoto 616-8255, Japan;
 yakuri{at}alles.or.jp

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

α Synuclein is a presynaptic protein highly and broadly expressed in the brain but its normal function is unknown.1 The protein is also termed non-amyloid β component precursor (NACP) because of its localisation in amyloid plaques of Alzheimer's disease.1 However, subsequent studies failed to confirm α synuclein as a component of the amyloid plaque.1 α Synuclein/NACP is now known to be a major component of Lewy bodies in Parkinson's disease (PD).1 Point mutations of the α synuclein gene found in three independent PD families suggest that α synuclein may participate in the aetiology of sporadic PD.1 To address this possibility, several groups reported case-control studies using a dinucleotide repeat polymorphism in the promoter region of the gene.2 The previous Japanese study by Izumi et al3 found a tendency of a lower frequency of allele 1 in Japanese PD patients …

View Full Text